Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Aetna close to buying Humana: Bloomberg

Published 06/26/2015, 03:25 AM
Updated 06/26/2015, 03:25 AM
© Reuters. A trader points up at a display on the floor of the New York Stock Exchange

(Reuters) - U.S. health insurer Aetna Inc (N:AET) is close to buying rival Humana Inc (N:HUM) and a deal could be signed as early as this weekend, Bloomberg reported, citing people familiar with the matter.

Humana has also received an offer from Cigna Corp (N:CI), but Humana's board prefers the offer from Aetna, Bloomberg reported.

Aetna and Humana were in talks, a source familiar with the matter told Reuters on Thursday, adding that there was no certainty Aetna would prevail. Cigna is also in the running, a second source confirmed to Reuters.

Aetna made a formal cash-and-stock bid this week to buy Humana, Bloomberg said.

Humana, which had a market value of $27.59 billion as of Thursday's close, was not immediately available for comment.

Aetna and Cigna declined to comment.

Reuters has previously reported that Humana is in takeover talks with Aetna and Cigna.

Bloomberg said discussions between Humana and Aetna intensified in the past few days after it emerged over the weekend that rivals Anthem Inc (N:ANTM) and Cigna had held merger talks of their own.

Anthem said on Saturday it had offered $47 billion in cash and stock for smaller rival Cigna, who rebuffed the offer the next day.

The intensifying talks come as insurers seek scale to trim administrative costs and negotiate lower prices with doctors, moves they say will make plans more affordable.

Aetna's shares jumped 4.3 percent to a record $133.05 after the report, while Humana's shares were up 6.5 percent at $196.21 in afternoon trading.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cigna shares rose 2.7 percent to a record high of $170.20, before giving up some gains to trade up 1 pct at $167.51.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.